Zacks Investment Research downgraded shares of Conmed Corporation (CNMD) from NEUTRAL to UNDERPERFORM on October 05, 2012, with a target price of $27.00.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on Conmed Corporation (CNMD),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment